Martina Bonechi

930 total citations
20 papers, 602 citations indexed

About

Martina Bonechi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Martina Bonechi has authored 20 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 8 papers in Genetics. Recurrent topics in Martina Bonechi's work include Advanced Breast Cancer Therapies (16 papers), Cancer-related Molecular Pathways (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Martina Bonechi is often cited by papers focused on Advanced Breast Cancer Therapies (16 papers), Cancer-related Molecular Pathways (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Martina Bonechi collaborates with scholars based in Italy, United States and United Kingdom. Martina Bonechi's co-authors include Ilenia Migliaccio, Luca Malorni, Angelo Di Leo, Chiara Biagioni, Matteo Benelli, Cristina Guarducci, Dario Romagnoli, Emanuela Risi, Amelia McCartney and Giulia Boccalini and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Martina Bonechi

19 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martina Bonechi Italy	14	463	448	207	165	136	20	602
Dario Romagnoli Italy	10	271 0.6×	254 0.6×	205 1.0×	88 0.5×	200 1.5×	23	467
Molly Catherine Hardebeck United States	9	543 1.2×	554 1.2×	271 1.3×	194 1.2×	327 2.4×	13	912
Francesca De Luca Italy	11	259 0.6×	446 1.0×	371 1.8×	80 0.5×	193 1.4×	18	610
Sonya C. Chapman United States	10	363 0.8×	412 0.9×	86 0.4×	128 0.8×	65 0.5×	17	552
Farhat Ghaznawi United States	5	245 0.5×	224 0.5×	170 0.8×	83 0.5×	173 1.3×	10	437
Manuel Ruíz Borrego Spain	12	242 0.5×	369 0.8×	166 0.8×	78 0.5×	178 1.3×	59	537
Ros Cutts United Kingdom	9	268 0.6×	296 0.7×	209 1.0×	47 0.3×	116 0.9×	15	431
A. Cseh Austria	12	401 0.9×	393 0.9×	163 0.8×	128 0.8×	176 1.3×	39	604
Sun Min Lim South Korea	5	291 0.6×	359 0.8×	108 0.5×	41 0.2×	153 1.1×	8	497
Zhanfang Guo United States	11	200 0.4×	335 0.7×	154 0.7×	63 0.4×	351 2.6×	19	585

Countries citing papers authored by Martina Bonechi

Since Specialization

Citations

This map shows the geographic impact of Martina Bonechi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martina Bonechi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martina Bonechi more than expected).

Fields of papers citing papers by Martina Bonechi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martina Bonechi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martina Bonechi. The network helps show where Martina Bonechi may publish in the future.

Co-authorship network of co-authors of Martina Bonechi

This figure shows the co-authorship network connecting the top 25 collaborators of Martina Bonechi. A scholar is included among the top collaborators of Martina Bonechi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martina Bonechi. Martina Bonechi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Migliaccio, Ilenia, Martina Bonechi, Dario Romagnoli, et al.. (2025). Single-cell transcriptomics reveals biomarker heterogeneity linked to CDK4/6 Inhibitor resistance in breast cancer cell lines. npj Breast Cancer. 11(1). 82–82.

Galardi, Francesca, Francesca De Luca, Chiara Biagioni, et al.. (2021). Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial. Breast Cancer Research. 23(1). 38–38. 25 indexed citations

McCartney, Amelia, Martina Bonechi, Francesca De Luca, et al.. (2020). Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd Trial. Clinical Cancer Research. 26(9). 2131–2139. 37 indexed citations

Migliaccio, Ilenia, Martina Bonechi, Amelia McCartney, et al.. (2020). CDK4/6 inhibitors: A focus on biomarkers of response and post-treatment therapeutic strategies in hormone receptor-positive HER2-negative breast cancer. Cancer Treatment Reviews. 93. 102136–102136. 21 indexed citations

Lorito, Nicla, Marina Bacci, Matteo Parri, et al.. (2020). Glucose Metabolic Reprogramming of ER Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib+. Cells. 9(3). 668–668. 26 indexed citations

McCartney, Amelia, Chiara Biagioni, Gaia Schiavon, et al.. (2019). Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor–positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT). European Journal of Cancer. 114. 55–66. 25 indexed citations

McCartney, Amelia, Ilenia Migliaccio, Martina Bonechi, et al.. (2019). Mechanisms of Resistance to CDK4/6 Inhibitors: Potential Implications and Biomarkers for Clinical Practice. Frontiers in Oncology. 9. 666–666. 114 indexed citations

Bonechi, Martina, Ilenia Migliaccio, Matteo Benelli, et al.. (2019). Abstract P6-09-02: Effects of palbociclib on thymidine kinase-1 (TK1) in hormone receptor positive (HR+) breast cancer cell lines. Cancer Research. 79(4_Supplement). P6–9. 2 indexed citations

Risi, Emanuela, Chiara Biagioni, Matteo Benelli, et al.. (2019). An RB-1 loss of function gene signature as a tool to predict response to neoadjuvant chemotherapy plus anti-HER2 agents: a substudy of the NeoALTTO trial (BIG 1-06). Therapeutic Advances in Medical Oncology. 11. 3862506648–3862506648. 3 indexed citations

10.

Guarducci, Cristina, Agostina Nardone, Ariel Feiglin, et al.. (2019). Abstract PD7-12: Inhibition of CDK7 overcomes resistance to CDK4/6 inhibitors in hormone receptor positive breast cancer cells. Cancer Research. 79(4_Supplement). PD7–12. 15 indexed citations

11.

Romagnoli, Dario, Giulia Boccalini, Martina Bonechi, et al.. (2018). ddSeeker: a tool for processing Bio-Rad ddSEQ single cell RNA-seq data. BMC Genomics. 19(1). 960–960. 16 indexed citations

12.

Guarducci, Cristina, Martina Bonechi, Matteo Benelli, et al.. (2018). Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer. npj Breast Cancer. 4(1). 38–38. 86 indexed citations

13.

Risi, Emanuela, Andrea Grilli, Ilenia Migliaccio, et al.. (2018). A gene expression signature of Retinoblastoma loss-of-function predicts resistance to neoadjuvant chemotherapy in ER-positive/HER2-positive breast cancer patients. Breast Cancer Research and Treatment. 170(2). 329–341. 18 indexed citations

14.

Malorni, Luca, Chiara Biagioni, Amelia McCartney, et al.. (2018). Role of serum thymidine kinase-1 (TK1) activity in patients (pts) with hormone receptor positive (HR+) advanced breast cancer (ABC) treated with endocrine therapy (ET) in the EFECT trial.. Journal of Clinical Oncology. 36(15_suppl). 12031–12031. 1 indexed citations

15.

Bonechi, Martina, Francesca Galardi, Chiara Biagioni, et al.. (2018). Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapy. Oncotarget. 9(23). 16389–16399. 31 indexed citations

16.

Guarducci, Cristina, Martina Bonechi, Giulia Boccalini, et al.. (2017). Mechanisms of Resistance to CDK4/6 Inhibitors in Breast Cancer and Potential Biomarkers of Response. Breast Care. 12(5). 304–308. 56 indexed citations

17.

Jeselsohn, Rinath, William T. Barry, Ilenia Migliaccio, et al.. (2016). TransCONFIRM: Identification of a Genetic Signature of Response to Fulvestrant in Advanced Hormone Receptor–Positive Breast Cancer. Clinical Cancer Research. 22(23). 5755–5764. 20 indexed citations

18.

Malorni, Luca, Silvano Piazza, Yari Ciani, et al.. (2016). A gene expression signature of retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients with ER positive early breast cancer. Oncotarget. 7(42). 68012–68022. 104 indexed citations

19.

Malorni, Luca, Chiara Biagioni, Cristina Guarducci, et al.. (2015). AP-2gamma as a novel biomarker of endocrine resistance: Results from the TransCONFIRM study. Annals of Oncology. 26. iii15–iii15. 1 indexed citations

20.

Malorni, Luca, Chiara Biagioni, J. Thirlwell, et al.. (2014). Efficacy of Fulvestrant According to Duration and Type of Adjuvant Endocrine Treatment, in Metastatic Breast Cancer Patients Enrolled in the Confirm Trial. Annals of Oncology. 25. i8–i8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact